$MDXG News

MiMedx Group, Inc. (MDXG) Q2 2026 Earnings Call Transcript

MIMEDX Group (NASDAQ:MDXG) Shares Fall After Q2 Revenue and EPS Slightly Miss Estimates

MiMedx Group Affirms FY2026 Sales Guidance of $260.000M-$290.000M vs $269.440M Est

MiMedx Group Q2 Adj. EPS $(0.05), Inline, Sales $64.362M Beat $63.460M Estimate

MiMedx Group (MDXG) Stock Faces Mixed Analyst Target Changes After Guidance Cut

How The MiMedx Group (MDXG) Story Is Shifting As Analysts Rework Price Targets

MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference

Is the Options Market Predicting a Spike in MiMedx Group Stock?

MiMedx: The Hard Math Behind My Downgrade To Hold

MIMEDX Announces Launch of G4Derm® Plus

Some May Be Optimistic About MiMedx Group's (NASDAQ:MDXG) Earnings

How Reimbursement Shifts Are Rewriting The MiMedx Group (MDXG) Investment Narrative

MiMedx Group, Inc. (NASDAQ:MDXG) Analysts Are Cutting Their Estimates: Here's What You Need To Know

MiMedx Group (MDXG) Launches CHORIOFIX Placental Allograft for Complex, Tunneling Wounds

Citizens Maintains Market Outperform on MiMedx Group, Lowers Price Target to $6

MiMedx Group Inc (MDXG) Q1 2026 Earnings Call Highlights: Navigating Growth and Challenges

MiMedx Group, Inc. (MDXG) Q1 2026 Earnings Call Transcript

MiMedx (MDXG) Reports Q1 Loss, Tops Revenue Estimates

MiMedx Group Q1 Earnings Call Highlights

MiMedx Group (NASDAQ:MDXG) Posts Disappointing Q1 Results, Stock Tumbles 8% After-Hours